These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27604084)

  • 1. Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine Therapy.
    Seinen ML; van Nieuw Amerongen GP; de Boer NK; van Bodegraven AA
    Mol Diagn Ther; 2016 Dec; 20(6):551-557. PubMed ID: 27604084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases.
    Atreya I; Diall A; Dvorsky R; Atreya R; Henninger C; Grün M; Hofmann U; Schaeffeler E; López-Posadas R; Daehn I; Zenker S; Döbrönti M; Neufert C; Billmeier U; Zundler S; Fritz G; Schwab M; Neurath MF
    J Crohns Colitis; 2016 Oct; 10(10):1132-43. PubMed ID: 27112707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rac1 Polymorphisms and Thiopurine Efficacy in Children With Inflammatory Bowel Disease.
    Lev-Tzion R; Renbaum P; Beeri R; Ledder O; Mevorach R; Karban A; Koifman E; Efrati E; Muise AM; Chowers Y; Turner D
    J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):404-7. PubMed ID: 25885881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac1 as a Potential Pharmacodynamic Biomarker for Thiopurine Therapy in Inflammatory Bowel Disease.
    Seinen ML; van Nieuw Amerongen GP; de Boer NK; Mulder CJ; van Bezu J; van Bodegraven AA
    Ther Drug Monit; 2016 Oct; 38(5):621-7. PubMed ID: 27465973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rac1/pSTAT3 expression: A pharmacodynamic marker panel as a first step toward optimization of thiopurine therapy in inflammatory bowel disease patients.
    Deben DS; van Adrichem AJ; Drent R; Puts S; Pelzer KEJM; van Bodegraven AA; Wong DR; Leers MPG
    Cytometry A; 2022 Feb; 101(2):167-176. PubMed ID: 34595833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Mercaptopurine reduces macrophage activation and gut epithelium proliferation through inhibition of GTPase Rac1.
    Marinković G; Hamers AA; de Vries CJ; de Waard V
    Inflamm Bowel Dis; 2014 Sep; 20(9):1487-95. PubMed ID: 25029617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patients.
    Deben DS; Creemers RH; van Adrichem AJ; Drent R; Merry AHH; Leers MPG; van Bodegraven AA; Wong DR
    Sci Rep; 2022 Sep; 12(1):15806. PubMed ID: 36138194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?
    Bourgine J; Garat A; Allorge D; Crunelle-Thibaut A; Lo-Guidice JM; Colombel JF; Broly F; Billaut-Laden I
    Pharmacogenet Genomics; 2011 Jun; 21(6):313-24. PubMed ID: 21372752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.
    Kuehn F; Klar E; Bliemeister A; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):221-8. PubMed ID: 25574094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
    Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
    J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients.
    Zabala W; Cruz R; Barreiro-de Acosta M; Chaparro M; Panes J; Echarri A; Esteve M; Carpio D; Andreu M; García-Planella E; Domenech E; Carracedo A; Gisbert JP; Barros F;
    Pharmacogenomics; 2013 Apr; 14(6):631-40. PubMed ID: 23570467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease.
    Parikh K; Zhou L; Somasundaram R; Fuhler GM; Deuring JJ; Blokzijl T; Regeling A; Kuipers EJ; Weersma RK; Nuij VJ; Alves M; Vogelaar L; Visser L; de Haar C; Krishnadath KK; van der Woude CJ; Dijkstra G; Faber KN; Peppelenbosch MP
    Sci Transl Med; 2014 Apr; 6(233):233ra53. PubMed ID: 24760188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between thiopurine exposure and depression in patients with inflammatory bowel disease and rheumatoid arthritis.
    Sutton SS; Magagnoli J; Cummings T; Hardin JW; Love BL
    J Psychopharmacol; 2020 Oct; 34(10):1163-1167. PubMed ID: 32126869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
    Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
    Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
    Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of GTPase Rac1 in endothelium by 6-mercaptopurine results in immunosuppression in nonimmune cells: new target for an old drug.
    Marinković G; Kroon J; Hoogenboezem M; Hoeben KA; Ruiter MS; Kurakula K; Otermin Rubio I; Vos M; de Vries CJ; van Buul JD; de Waard V
    J Immunol; 2014 May; 192(9):4370-8. PubMed ID: 24670805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.
    Atreya R; Atreya I; Neurath MF
    Ann N Y Acad Sci; 2006 Aug; 1072():98-113. PubMed ID: 17057193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
    Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE
    Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Heerasing NM; Ng JF; Dowling D
    Intern Med J; 2016 Apr; 46(4):465-9. PubMed ID: 26425841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
    Uhlig HH
    Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.